Hepatitis B virus antigen-specific T lymphocyte response

Hepatitis B virus antigen-specific T lymphocyte response describes the activity of adaptive immune cells (primarily CD8⁺ cytotoxic T cells and CD4⁺ helper T cells) that recognize and respond to HBV-derived proteins (such as hepatitis B surface antigen [HBsAg], core antigen [HBcAg], and polymerase epitopes)[2][3][6]. These T cells are crucial for the elimination of infected hepatocytes and long-term control of HBV infection. In acute infection, robust, multifunctional T cell responses are associated with viral clearance, while in chronic infection, these responses are often weak, dysfunctional, or "exhausted" due to continuous antigen exposure and inhibitory signaling[1][6][7]. The phenotype and frequency of these T cells are important research and clinical biomarkers for monitoring HBV infection, guiding immunotherapeutic strategies, and predicting treatment response. However, this term reflects an immune process, not a singular druggable protein target[2][3][6][7].

Other names

HBV antigen-specific T cell responseHBV-specific T lymphocyte responseHepatitis B virus-specific T cell response

Modulate or restore T cell function (e.g., with checkpoint blockade); Enhance antigen-specific cytotoxicity or cytokine secretion